GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,983.00p
   
  • Change Today:
    -0.50p
  • 52 Week High: 2,208.00
  • 52 Week Low: 1,344.00
  • Currency: UK Pounds
  • Shares Issued: 4,046.44m
  • Volume: 13,837,755
  • Market Cap: £80,241m
  • RiskGrade: 129
  • Beta: 0.00

Latest ShareCast News

GSK's momelotinib receives orphan drug designation from US and EU watchdogs

By Iain Gilbert

Date: Friday 12 Jun 2026

(Sharecast News) - Drugmaker GSK said on Friday that its JAK inhibitor momelotinib has been granted orphan drug designation by both the US Food and Drug Administration and the European Medicines Agency for the treatment of VEXAS syndrome, a rare and severe autoinflammatory condition with no approved therapies.

GSK ShareCast News

GSK to buy Boston-based biopharma firm Nuvalent ... 09-Jun-2026 ShareCast
Trials show GSK drug cures hepatitis B in nearly... 28-May-2026 ShareCast
Citi sees buying opportunity at AstraZeneca afte... 18-May-2026 ShareCast
GSK strikes agreement with China's SBP Group, la... 11-May-2026 ShareCast
Sales jump at GSK on strong demand for specialty... 29-Apr-2026 ShareCast

GSK Regulatory News

Holding(s) in Company 26-Jun-2026 15:00 RNS
Director/PDMR Shareholding 24-Jun-2026 15:30 RNS
GSK announces tender offer to acquire Nuvalent 24-Jun-2026 14:52 RNS
Director/PDMR Shareholding 23-Jun-2026 15:30 RNS
Transaction in Own Shares 22-Jun-2026 15:00 RNS

GSK Newspaper Links

GSK to buy US cancer treatment firm Nuvalent for... 09-Jun-2026 Guardian
GSK signs £45m deal with UCL offshoot for liver ... 08-Jun-2026 Times
Strong vaccine sales deliver an early boost for ... 29-Apr-2026 Times
GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph
Glaxo sharpens axe to save £1bn as insurers and ... 01-Dec-2014 The Independent

GSK Tips & Analysis

Questor :GlaxoSmithKline 16-Apr-2014 Telegraph
Questor:GlaxoSmithKline 06-Oct-2011 Telegraph
Questor:GlaxoSmithKline 11-Aug-2011 Telegraph
Questor tip: GlaxoSmithKline 28-Jul-2011 Telegraph
Investment Column: GlaxoSmithKline 27-Jul-2011 The Independent

GSK News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
Study Found That Long Term Use of Advair Diskus(... 29-Oct-2008 PR Newswire
GlaxoSmithKline to Acquire Genelabs Technologies... 29-Oct-2008 PR Newswire
A New Interactive Consumer Experience Highlighti... 28-Sep-2007 PR Newswire
AUDIO from Medialink and GlaxoSmithKline: A New ... 28-Sep-2007 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,983.00p
Change Today -0.50p
% Change -0.03 %
52 Week High 2,208.00
52 Week Low 1,344.00
Volume 13,837,755
Shares Issued 4,046.44m
Market Cap £80,241m
Beta 0.00
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average
36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 13
Sell 3
Strong Sell 0
Total 23
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 14-May-26 19-Feb-26
Paid 09-Jul-26 09-Apr-26
Amount 17.00p 18.00p

Trades for 26-Jun-2026

Time Volume / Share Price
16:35 418,933 @ 1,983.00p
17:12 2,896,693 @ 1,972.50p
16:51 9,126 @ 1,983.00p
16:51 116 @ 1,983.00p
16:51 25,692 @ 1,983.00p

GSK Key Personnel

CEO Luke Miels

Top of Page